Total cardiovascular or fatal events in people with type 2 diabetes and cardiovascular risk factors treated with dulaglutide in the REWIND trail: a post hoc analysis
暂无分享，去创建一个
G. Dagenais | P. Pais | P. López-Jaramillo | Lawrence A Leiter | M. Keltai | W. Sheu | J. Shaw | W. Cushman | L. Rydén | H. Gerstein | J. Probstfield | J. Basile | M. Riddle | F. Lanas | S. Hall | I. Conget | N. Pogosova | H. Colhoun | C. Atisso | M. Lakshmanan | V. Pīrāgs | L. Dyal | P. Raubenheimer | T. Temelkova-Kurktschiev | Ernesto German Cordona Munoz | J. Shaw | V. Pirags